Cardio Diagnostics Holdings, Inc.
CDIO
$1.94
-$0.05-2.51%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -16.08% | -57.31% | -55.74% | -50.13% | -39.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -16.08% | -57.31% | -55.74% | -50.13% | -39.51% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -16.08% | -57.31% | -55.74% | -50.13% | -39.51% |
| SG&A Expenses | 6.74% | -30.83% | -26.88% | -30.40% | -43.51% |
| Depreciation & Amortization | 8.60% | 351.43% | 578.13% | 352.08% | 239.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 13.60% | -22.64% | -22.24% | -26.13% | -39.79% |
| Operating Income | -13.70% | 22.49% | 22.10% | 26.01% | 39.79% |
| Income Before Tax | -13.60% | 22.49% | 20.61% | 28.76% | 49.12% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -13.60% | 22.49% | 20.61% | 28.76% | 49.12% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -13.60% | 22.49% | 20.61% | 28.76% | 49.12% |
| EBIT | -13.70% | 22.49% | 22.10% | 26.01% | 39.79% |
| EBITDA | -14.75% | 24.77% | 24.44% | 28.75% | 42.85% |
| EPS Basic | 39.36% | 64.68% | 64.80% | 67.15% | 77.52% |
| Normalized Basic EPS | 39.36% | 64.68% | 66.81% | 69.22% | 77.44% |
| EPS Diluted | 39.36% | 64.68% | 64.80% | 67.15% | 77.52% |
| Normalized Diluted EPS | 39.36% | 64.68% | 66.81% | 69.22% | 77.44% |
| Average Basic Shares Outstanding | 78.60% | 95.39% | 123.65% | 123.32% | 120.19% |
| Average Diluted Shares Outstanding | 78.60% | 95.39% | 123.65% | 123.32% | 120.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |